STOCK TITAN
  1. Home
  2. News
  3. BAX

Baxter International Inc. - BAX STOCK NEWS

Welcome to our dedicated page for Baxter International news (Ticker: BAX), a resource for investors and traders seeking the latest updates and insights on Baxter International stock.

Baxter International Inc. (NYSE: BAX) is a global healthcare company dedicated to providing essential renal and hospital products. With a comprehensive portfolio that includes home, acute, and in-center dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition, biosurgery products, anesthetics, and pharmacy automation, Baxter plays a critical role in expanding access to healthcare worldwide.

Baxter's recent acquisition of Hillrom in late 2021 has significantly enhanced its hospital-focused offerings. This acquisition brought basic equipment like hospital beds under Baxter’s umbrella, along with advanced digital solutions such as smart beds and the Voalte medical communications app. These additions complement Baxter’s legacy operations, which focus on products for patients with acute and chronic kidney failure. Notably, Baxter plans to spin off its renal care segment by mid-2024.

Additionally, Baxter provides a variety of injectable therapies, including IV pumps, administrative sets, and nutritional products, as well as surgical sealants and hemostatic agents used in various care settings. The company’s extensive global footprint and the essential nature of its products and services underscore its commitment to advancing healthcare innovations and improving patient care in both emerging and developed markets.

Baxter’s financial condition remains robust, bolstered by its continuous innovation and strategic partnerships. The company’s employees worldwide are dedicated to building upon a rich heritage of medical breakthroughs, ensuring that Baxter continues to be at the forefront of healthcare advancements.

News

Baxter Declares Quarterly Dividend

Rhea-AI Summary
Baxter International Inc. (BAX) declares a quarterly cash dividend of $0.29 per share, with an annual rate of $1.16, payable on April 1, 2024, to stockholders of record as of March 1, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.71%
Tags
dividends
-
News

Baxter Reports Fourth-Quarter and Full-Year 2023 Results

Rhea-AI Summary
Baxter International Inc. reported a 4% increase in fourth-quarter sales, reaching $3.89 billion. Full-year sales grew by 2% to $14.81 billion. The company's U.S. GAAP diluted EPS from continuing operations was $0.14 for the fourth quarter and ($0.15) for the full year. Adjusted diluted EPS from continuing operations was $0.88 for the fourth quarter and $2.60 for the full year. Baxter is preparing for the proposed separation of its Kidney Care segment into a standalone company named Vantive. The company reported strong sales growth in the Healthcare Systems and Technologies segment, while Kidney Care sales declined. Baxter also highlighted key strategic priorities and corporate responsibility initiatives for 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.74%
Tags
earnings
-
News

Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors

Rhea-AI Summary
Baxter International Inc. (BAX) will host a conference call to discuss its fourth-quarter 2023 financial results on February 8, 2024, at 7:30 a.m. Central Time. Participants can pre-register for the call and access the webcast through Baxter's website. The call will be recorded and is copyrighted material.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.37%
Tags
conferences earnings
News

Baxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. Hospitals

Rhea-AI Summary
Baxter International Inc. (NYSE:BAX) has successfully completed the first phase of its intravenous (IV) bag recycling program pilot in collaboration with Northwestern Memorial Hospital, diverting more than six tons of polyvinyl chloride (PVC) IV bag waste from landfills. This innovative program demonstrates Baxter's commitment to corporate responsibility and waste reduction, with plans to expand the program to support scalability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.51%
Tags
none
-
News

Baxter to Present at 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary
Baxter International Inc. (BAX) to present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024. José (Joe) E. Almeida, Chairman, President, and CEO, will present at 10:30 a.m. Pacific Time. The live webcast can be accessed at www.baxter.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.51%
Tags
conferences
-
News

Baxter Publishes Task Force on Climate-Related Financial Disclosures (TCFD) Report and Is Named to Dow Jones Sustainability Index North America

Rhea-AI Summary
Baxter International Inc. (NYSE:BAX) published its first report aligned with the Task Force on Climate-related Financial Disclosures (TCFD) recommendations, showcasing the company's commitment to transparency and strong disclosure in managing climate-related risks and opportunities. The report is designed to improve climate-related disclosure relevant to investors and key stakeholders, as Baxter continues to make a positive impact on patients, the planet, and communities. Baxter has been named to the Dow Jones Sustainability Index (DJSI) North America for 2023, marking its continuous inclusion in DJSI North America since 2005.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
none
News

The Baxter International Foundation and UNICEF Partner to Expand Access to Safe Water and Sanitation in Egypt

Rhea-AI Summary
Baxter International Inc. (BAX) partners with UNICEF to improve access to safe drinking water and sanitation in Egypt with a $2.5 million grant. This three-year initiative aims to implement climate-smart water, sanitation, and hygiene (WASH) programming for thousands of people in Upper Egypt’s governorates of Aswan, Assiut, Quena, Minya, and Luxor through community engagement, education, and rehabilitation of primary health units.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.22%
Tags
partnership
-
News

Baxter Declares Quarterly Dividend

Rhea-AI Summary
Baxter International Inc. (NYSE:BAX) Declares Quarterly Dividend of $0.29 per Share, Payable on January 2, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.79%
Tags
dividends
-
News

Baxter Highlights New Data at Kidney Week Indicating Sharesource Is Associated With a 77% Lower Risk of Home Dialysis Technique Failure

Rhea-AI Summary
Baxter International Inc. announces new data indicating that its Sharesource remote patient management platform is associated with a 77% reduction in risk of peritoneal dialysis technique failure. Additionally, the HDx therapy enabled by Theranova dialyzer can help reduce water consumption by 27% and electricity usage by 17% compared to hemodiafiltration.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.56%
Tags
none
News

Baxter Reports Third-Quarter 2023 Results

Rhea-AI Summary
Baxter International Inc. reported third-quarter revenue of $3.71 billion, a 3% increase on a reported basis and 2% increase on a constant currency basis. The company's adjusted EPS from continuing operations was $0.68, exceeding guidance. Baxter has implemented a new operating model with four verticalized business segments. The company completed the divestiture of its BioPharma Solutions business and is progressing with the planned spinoff of its Kidney Care segment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.45%
Tags
earnings

FAQ

What is the current stock price of Baxter International (BAX)?

The current stock price of Baxter International (BAX) is $32.63 as of November 20, 2024.

What is the market cap of Baxter International (BAX)?

The market cap of Baxter International (BAX) is approximately 16.6B.

What does Baxter International Inc. specialize in?

Baxter specializes in essential renal and hospital products, including dialysis, sterile IV solutions, infusion systems, parenteral nutrition, biosurgery products, anesthetics, and pharmacy automation.

What was the impact of Baxter's acquisition of Hillrom?

The acquisition of Hillrom in late 2021 enhanced Baxter's hospital-focused offerings with additional equipment like hospital beds and digital solutions such as smart beds and the Voalte medical communications app.

What products does Baxter offer for kidney failure patients?

Baxter provides tools for patients with acute and chronic kidney failure, including home, acute, and in-center dialysis solutions.

What are some of Baxter's injectable therapies?

Baxter offers a range of injectable therapies, including IV pumps, administrative sets, and nutritional products.

What surgical products does Baxter provide?

Baxter provides surgical sealants and hemostatic agents used in various care settings.

What is Baxter's plan for its renal care segment?

Baxter plans to spin off its renal care segment by mid-2024.

How does Baxter contribute to global healthcare access?

Baxter’s global footprint and essential products play a key role in expanding access to healthcare in both emerging and developed countries.

How does Baxter ensure continuous innovation?

Baxter builds upon a rich heritage of medical breakthroughs and strategically partners to advance the next generation of healthcare innovations.

What are some of the digital solutions offered by Baxter?

Baxter offers digital solutions like smart beds and the Voalte medical communications app, acquired through Hillrom.

What is Baxter's commitment to patient care?

Baxter is committed to improving patient care by providing essential medical products, fostering healthcare innovations, and maintaining a robust financial condition.

Stock BAX logo
Baxter International Inc.

NYSE:BAX

BAX Rankings

#620 Ranked by Market Cap
#1355 Ranked by Dividends

BAX Stock Data

16.63B
508.41M
0.38%
94.45%
2.25%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
DEERFIELD